Factor V Leiden Mutation Test at Lahore PCR Lab

Factor V Leiden Mutation Test at Lahore PCR Lab

The Factor V Leiden mutation test is a specialized molecular genetic assay designed to identify a specific genetic variation in the F5 gene, which encodes the coagulation Factor V protein. Factor V plays a pivotal role in the human coagulation cascade, serving as an essential cofactor in the prothrombinase complex. Under normal physiological conditions, this complex facilitates the conversion of prothrombin to thrombin, which subsequently converts soluble fibrinogen into insoluble fibrin strands to form a stable blood clot. To prevent excessive clotting, the coagulation process is tightly regulated by Activated Protein C (APC). APC downregulates the clotting cascade by cleaving and inactivating Factor V at specific molecular sites, primarily at the Arginine 506 position. However, individuals with the Factor V Leiden mutation possess a single nucleotide polymorphism (SNP) where guanine is substituted by adenine at nucleotide position 1691 of the F5 gene (G1691A). This genetic alteration leads to an amino acid substitution of glutamine for arginine at position 506 (Arg506Gln). Because of this structural modification, the mutant Factor V protein resists inactivation by APC, a phenomenon known as Activated Protein C resistance. Consequently, the coagulation cascade remains active for a longer duration, significantly increasing the predisposition to venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).

At Lahore PCR Lab in Lahore, Pakistan, this mutation is detected using advanced molecular diagnostics, specifically real-time Polymerase Chain Reaction (PCR) technology. This highly sensitive and specific method amplifies the target region of the F5 gene, allowing for the precise identification of the patient’s genotype. The test determines whether an individual is homozygous (carrying two copies of the mutated gene), heterozygous (carrying one mutated copy and one normal copy), or wild-type (carrying two normal copies). Understanding this genetic status is of paramount clinical importance, as it helps clinicians assess a patient’s lifelong risk of thrombotic events, guide the duration and intensity of anticoagulant therapy, and make informed decisions regarding family screening, pregnancy management, and the use of estrogen-containing medications.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the Factor V Leiden mutation test at Lahore PCR Lab is straightforward, as it is a DNA-based molecular assay. Patients should observe the following guidelines to ensure a smooth testing process:

• No Fasting Required: Unlike certain metabolic or lipid panels, you do not need to fast before this test. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff about all medications you are currently taking, especially anticoagulants such as warfarin, heparin, or direct oral anticoagulants (DOACs). While these medications do not interfere with the PCR-based genetic test, they are critical for interpreting your overall clinical picture.
• No Interruption of Anticoagulants: You do not need to stop taking your blood thinners or any other prescribed medications for this genetic test, as DNA sequence analysis is unaffected by active anticoagulation.
• Hydration: Staying well-hydrated by drinking plenty of water before the blood draw can make venipuncture easier by keeping your veins full and accessible.
• Identification and Documentation: Bring your doctor’s prescription, national identity card, and any relevant medical history records regarding previous blood clots or family history of thrombophilia to Lahore PCR Lab.

During the Procedure

The collection of the sample for the Factor V Leiden mutation test at Lahore PCR Lab is a quick and minimally invasive procedure performed by experienced phlebotomists:

• Patient Positioning: You will be asked to sit comfortably in a blood collection chair. The phlebotomist will ask you to extend your arm and rest it on a supportive armrest.
• Site Selection and Sanitization: The phlebotomist will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the crease of the elbow). Once selected, the area is thoroughly cleansed with an antiseptic swab to prevent contamination.
• Tourniquet Application: A soft elastic band (tourniquet) is tied around your upper arm to temporarily restrict blood flow, causing the veins to swell and become more visible and accessible.
• Sample Collection: A sterile, single-use needle is gently inserted into the vein. A whole blood specimen is drawn into an EDTA (ethylenediaminetetraacetic acid) tube, which is characterized by a lavender or purple top. EDTA is the preferred anticoagulant for molecular testing as it preserves cellular DNA.
• Needle Removal and Hemostasis: Once the required volume of blood is collected, the tourniquet is released, the needle is gently withdrawn, and a sterile cotton ball or gauze is pressed against the puncture site to stop any bleeding. A small adhesive bandage is then applied.
• Duration and Experience: The entire venipuncture process takes less than five minutes. You may feel a brief, mild pinch as the needle enters the skin, but the procedure is generally painless.
• Safety and Processing: Lahore PCR Lab adheres to strict biosafety and quality control standards. The collected sample is immediately labeled with your unique patient identification details and transferred to the molecular diagnostics department for DNA extraction and real-time PCR analysis.

When is a Factor V Leiden Mutation Test Performed?

Unexplained Venous Thromboembolism (VTE)

Physicians frequently request the Factor V Leiden mutation test when a patient experiences an unexplained or unprovoked venous thrombotic event. This includes deep vein thrombosis (DVT), which is a blood clot in the deep veins of the legs, or a pulmonary embolism (PE), where a clot travels to the lungs. Identifying the underlying genetic cause, such as the G1691A mutation, helps clinicians determine the risk of recurrence and decide whether long-term or lifelong anticoagulant therapy is necessary to prevent future life-threatening events.

Recurrent Pregnancy Loss (Miscarriages)

Recurrent pregnancy loss, defined as two or more consecutive miscarriages, is a significant clinical indication for thrombophilia screening. The Factor V Leiden mutation can lead to microvascular thrombosis in the developing placental circulation, compromising blood flow to the fetus and resulting in early miscarriage, late-term fetal loss, intrauterine growth restriction (IUGR), or preeclampsia. Identifying this mutation allows obstetricians to implement appropriate prophylactic measures, such as low-molecular-weight heparin (LMWH), to improve pregnancy outcomes.

Strong Family History of Thrombophilia

A strong family history of early-onset blood clots, sudden unexplained deaths due to pulmonary embolism, or known Factor V Leiden mutation in first-degree relatives warrants genetic testing. Because the mutation is inherited in an autosomal dominant fashion, offspring and siblings of affected individuals have a high probability of carrying the gene. Testing asymptomatic family members helps them understand their risk profile and take preventive measures during high-risk situations like major surgeries, prolonged travel, or pregnancy.

Estrogen-Containing Therapy Evaluation

Before initiating estrogen-containing medications, such as combined oral contraceptive pills (COCPs) or hormone replacement therapy (HRT), physicians may recommend a Factor V Leiden test for women with a personal or family history of clotting. Estrogen naturally increases the levels of several clotting factors and decreases natural anticoagulants. When combined with the genetic resistance to Activated Protein C caused by the Factor V Leiden mutation, the risk of developing a venous thromboembolism increases exponentially, making alternative non-hormonal therapies preferable.

Early-Onset Blood Clots (Before Age 50)

Developing a blood clot at a young age, typically before 50, is highly unusual and strongly suggests an inherited predisposition. When a young patient presents with a DVT, PE, or thrombosis in atypical sites—such as the cerebral venous sinuses, portal vein, mesenteric veins, or hepatic veins (Budd-Chiari syndrome)—the Factor V Leiden mutation test is a critical component of the diagnostic workup. Pinpointing the genetic defect helps tailor acute management and long-term preventive strategies for these young individuals.

What Does a Factor V Leiden Mutation Test Detect?

The Factor V Leiden mutation test at Lahore PCR Lab is a highly precise molecular assay that directly analyzes the patient’s genomic DNA. It is designed to detect the presence or absence of the specific G1691A mutation in the F5 gene. The test provides key clinical insights by identifying the following genetic states and associated risk factors:

• Wild-Type Genotype (Normal): The test detects two normal copies of the F5 gene (GG genotype). This indicates the absence of the Factor V Leiden mutation, meaning the patient’s Factor V protein can be normally inactivated by Activated Protein C, and they do not have this specific inherited risk factor for thrombophilia.
• Heterozygous Mutation: The test detects one normal copy and one mutated copy of the F5 gene (GA genotype). This indicates the patient has inherited the mutation from one parent. Heterozygous individuals have a moderately increased risk of developing venous thromboembolism, estimated to be 3 to 8 times higher than the general population.
• Homozygous Mutation: The test detects two mutated copies of the F5 gene (AA genotype), indicating the mutation was inherited from both parents. This is a rare but severe condition that increases the risk of venous thromboembolism by 50 to 80 times compared to the general population, often requiring lifelong anticoagulation management.
• Activated Protein C (APC) Resistance: By confirming the genetic mutation, the test indirectly detects the molecular basis for APC resistance, where the mutant Factor V molecule cannot be cleaved at the Arg506 site, allowing the clotting cascade to proceed unchecked.
• Inherited Thrombophilia Risk: The test establishes whether a patient’s thrombotic event has a hereditary basis, distinguishing it from purely acquired risk factors such as surgery, trauma, or prolonged immobilization.
• Risk of Recurrent Thrombosis: It helps quantify the likelihood of a recurrent blood clot, which is crucial for determining the optimal duration of blood thinner therapy after an initial DVT or PE.
• Pregnancy-Related Complications Risk: It identifies women who are at an elevated risk for placental thrombosis, preeclampsia, placental abruption, and fetal growth restriction, enabling proactive obstetric care.
• Synergistic Risk with Estrogen: It highlights an extreme increase in thrombotic risk if the patient uses estrogen-containing contraceptives or hormone replacement therapy, guiding clinicians to recommend safer alternatives.
• Atypical Site Thrombosis Association: It explains the genetic etiology behind unusual thrombotic events, such as portal vein thrombosis, mesenteric vein thrombosis, or cerebral venous sinus thrombosis.
• Family Planning Insights: It provides essential genetic information for family planning, helping prospective parents understand the risk of passing the mutation to their offspring.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab is dedicated to providing timely, accurate, and reliable molecular diagnostic services to patients in Lahore and surrounding areas. Because the Factor V Leiden mutation test involves complex molecular techniques, including DNA extraction, PCR amplification, and sequence analysis, the turnaround time is typically within 3 to 5 working days. This timeline ensures that our highly trained molecular pathologists can perform rigorous quality control checks and verify the accuracy of the genetic findings.

Once the analysis is complete, the final report is reviewed and signed by a consultant pathologist. Lahore PCR Lab offers convenient and secure digital report access to ensure patients and their physicians receive results promptly. Patients can access their reports online through the official Lahore PCR Lab web portal using their unique patient ID and password. Additionally, reports can be sent directly via WhatsApp or email, reducing the need for a physical visit to the lab. For those who prefer physical copies, reports can be collected directly from our main diagnostic center in Lahore.

Factor V Leiden Mutation Test Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
F5 Gene Nucleotide 1691	Guanine/Guanine (GG) – Wild Type	Guanine/Adenine (GA) or Adenine/Adenine (AA)
Factor V Protein Structure	Normal Arginine at position 506	Glutamine substitution at position 506 (Arg506Gln)
Activated Protein C (APC) Sensitivity	Normal inactivation of Factor V by APC	Resistance to APC-mediated cleavage and inactivation
Zygosity Status	Negative for mutation (Wild Type)	Heterozygous (one mutated allele) or Homozygous (two mutated alleles)
Relative Risk of VTE	Baseline population risk	3-8 fold increase (Heterozygous); 50-80 fold increase (Homozygous)
Clinical Coagulation Profile	Balanced coagulation and fibrinolysis	Hypercoagulable state with propensity for venous thrombosis
Family Risk Assessment	No inherited Factor V Leiden risk to offspring	50% chance of passing mutation (Heterozygous); 100% chance (Homozygous)
Prophylactic Anticoagulation Needs	Standard clinical care during high-risk events	Indicated during high-risk events (surgery, pregnancy, immobilization)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Factor V Leiden Mutation Test?

• Experienced healthcare professionals: Our team consists of highly qualified molecular biologists, geneticists, and consultant pathologists who specialize in advanced genetic testing.
• Patient-focused care: We prioritize patient comfort, safety, and understanding throughout the testing process, offering guidance and clear explanations.
• Quality diagnostic services: Lahore PCR Lab adheres to stringent international quality standards and internal quality control protocols to ensure maximum accuracy.
• Professional reporting: Our genetic reports are comprehensive, detailed, and structured to provide clear, actionable insights for your treating physician.
• Modern diagnostic approach: We utilize state-of-the-art real-time PCR technology and advanced DNA extraction methodologies for reliable genetic analysis.
• Comfortable environment: Our diagnostic centers in Lahore are designed to provide a clean, hygienic, and welcoming environment for all patients.
• Convenient location: Situated in a highly accessible area of Lahore, our laboratory is easy to reach for patients seeking specialized diagnostics.
• Commitment to accurate diagnosis: We are dedicated to delivering precise genetic profiles, helping patients and doctors make critical healthcare decisions with confidence.